Searchable abstracts of presentations at key conferences in endocrinology
ISSN 1470-3947 (print)
| ISSN 1479-6848 (online)
Endocrine Abstracts
Menu
Search
Issues/Conferences
Cite
About
Our Services
Policies
Contact
Disclaimer
Search
Issues/Conferences
Cite
About
Our Services
Policies
Contact
Disclaimer
Previous issue
|
Volume 24
|
BSPED2010
|
Next issue
38th Meeting of the British Society for Paediatric Endocrinology and Diabetes
All volumes
0105 UKINETS2024
0104 SFEIES24
0103 BSPED2024
0102 EYES2024
0101 ETA2024
0100 SFEEU2024
0099 ECE2024
0098 NANETS2023
0097 BES2023
0096 UKINETS2023
0095 BSPED2023
0094 SFEBES2023
0093 EYES2023
0092 ETA2023
0091 SFEEU2023
0090 ECE2023
0089 NANETS2022
0088 BES2022
0087 UKINETS2022
0086 SFEBES2022
0085 BSPED2022
0084 ETA2022
0083 EYES2022
0082 SFEEU2022
0081 ECE2022
0080 UKINETS2021
0079 BES2021
0078 BSPED2021
0077 SFEBES2021
0076 CHD2021
0075 EYES2021
0074 SFENCC2021
0073 ECE2021
0072 UKINETS2020
0071 BES2020
0070 ECE2020
0069 SFENCC2020
0068 UKINETS2019
0067 EYES2019
0066 BSPED2019
0065 SFEBES2019
0064 BES2019
0063 ECE2019
0062 EU2019
0061 OU2019
0060 UKINETS2018
0059 SFEBES2018
0058 BSPED2018
0057 BES2018
0056 ECE2018
0055 SFEEU2018
0054 NuclearReceptors2018
0053 OU2018
0052 UKINETS2017
0051 BSPED2017
0050 SFEBES2017
0049 ECE2017
0048 SFEEU2017
0047 Theranostics2016
0046 UKINETS2016
0045 BSPED2016
0044 SFEBES2016
0043 WCTD2016
0042 Androgens2016
0041 ECE2016
0040 ESEBEC2016
0039 BSPED2015
0038 SFEBES2015
0037 ECE2015
0036 BSPED2014
0035 ECE2014
0034 SFEBES2014
0033 BSPED2013
0032 ECE2013
0031 SFEBES2013
0030 BSPED2012
0029 ICEECE2012
0028 SFEBES2012
0027 BSPED2011
0026 ECE2011
0025 SFEBES2011
0024 BSPED2010
0023 BSPED2009
0022 ECE2010
0021 SFEBES2009
0020 ECE2009
0019 SFEBES2009
0018 MES2008
0017 BSPED2008
0016 ECE2008
0015 SFEBES2008
0014 ECE2007
0013 SFEBES2007
0012 SFE2006
0011 ECE2006
0010 SFE2005
0009 BES2005
0008 SFE2004
0007 BES2004
0006 SFE2003
0005 BES2003
0004 SFE2002
0003 BES2002
0002 SFE2001
Summary
Abstract Book
Programme
Volume Editors
Abstracts
Contents
Speaker Abstracts
CME session
Adrenal development, function and failure
ea0024s1
Congenital adrenal hyperplasia
ea0024s2
Cushing's disease
ea0024s3
Physiology and developmental biology
ea0024s4
Clinical evaluation of suspected cases of DSD
ea0024s5
What is going through the surgeon's mind when he is sitting in the DSD clinic?
ea0024s6
RCN CYP diabetes community session
IT barriers and potential solutions
ea0024s7
Regional networks and PBR
ea0024s8
Child protection and social service challenges
ea0024s9
Cultural barriers to effective DM management
ea0024s10
Accreditation in paediatric diabetes in the UK and England
ea0024s11
A recipe for business success ... and staff motivation
ea0024s12
Enabling sustained improvements on CSII: how to fine tune!
ea0024s13
First hand experience of diabetes services: challenges and solutions
ea0024s14
Symposium 1 – Transition and Therapeutics
GH replacement into adult life
ea0024s15
Sex hormone replacement and fertility for adolescents and young adults: who needs it and how should it be done?
ea0024s16
Steroid replacement
ea0024s17
Symposium 2 – Metabolic Bone Disease
Vitamin D in health and disease
ea0024s18
New developments in phosphate metabolism: understanding the mechanisms of hypophosphataemic rickets
ea0024s19
Catherine Hall Memorial Lecture
Catherine Hall Memorial Lecture: Congenital hyperinsulinism and DOPA-PET CT
ea0024s20
Symposium 3 – The Beta cell
Altered beta-cell signalling and congenital hyperinsulinism of infancy (CHI)
ea0024s21
The yin and yang of beta cell genetics
ea0024s22
Neonatal diabetes
ea0024s23
Plenary guest lecture
Practical use of continuous glucose monitoring
ea0024s24
Symposium 4 – Diabetes Care
Corneal confocal microscopy and diabetic neuropathy
ea0024s25
Living with diabetes: normal but different, different but normal
ea0024s26
Endocrine Nurse session
RCN CYP specialist care forum: endocrine community update
ea0024s27
Endocrine Nursing: raising the profile
ea0024s28
Survivorship, what it is and where it is going?
ea0024s29
Psychological impact of chronic illness for children and families
ea0024s30
Oral Communications
Oral Communications 1
Longitudinal FT4 levels in the first 4 weeks of life are an independent factor affecting brain growth in extreme preterm babies born [lt]28 weeks' gestation
ea0024oc1.1
Growth Hormone Deficiency in children is associated with selective cognitive deficits
ea0024oc1.2
Semen cryopreservation in adolescent minors with cancer: a 10-year experience
ea0024oc1.3
The Growth Hormone Receptor Exon 3 Deleted Polymorphism is Associated with Birth and Placental Weight
ea0024oc1.4
Factors affecting changes in insulin sensitivity and insulin secretion during Growth Hormone treatment in children born small for gestational age
ea0024oc1.5
Altered Metabolomic Profile in Children Born Small for Gestational Age without Post-Natal Catch-up Growth
ea0024oc1.6
Enhancement of the canonical Wnt pathway in Rathke's pouch results in pituitary tumours reminiscent of human adamantinomatous craniopharyngioma
ea0024oc1.7
Clinical and Molecular Characterisation of 300 patients with Congenital Hyperinsulinism
ea0024oc1.8
Oral Communications 2 (Brief Communications)
Space-time clustering of elevated TSH levels on newborn screening
ea0024oc2.1
An unbalanced maternal diet in pregnancy is associated with epigenetic effects in the offspring
ea0024oc2.2
The phenotype of late-presenting congenital hyperinsulinism
ea0024oc2.3
Morbidity and Mortality of Infants with Salt Wasting Congenital Adrenal Hyperplasia in an Unscreened Population
ea0024oc2.4
Correlation of clinical and functional data to predict pubertal outcome in PAIS
ea0024oc2.5
Novel TSHR mutations in a large cohort of consanguineous families with congenital non-goitrous hypothyroidism
ea0024oc2.6
Wide range of eye abnormalities in patients with hypopituitarism: is this showing a novel genetic aetiology?
ea0024oc2.7
Radio-iodine therapy for autoimmune hyperthyroidism. A two centre, retrospective evaluation of practice and outcomes
ea0024oc2.8
Oral Communications 3
Altered Expression of HCN Channels in Patients with Congenital Hyperinsulinism of Infancy (CHI)
ea0024oc3.1
In vitro recovery of functional KATP channels in congenital hyperinsulinism of infancy (CHI)
ea0024oc3.2
Are there practical alternatives to the inpatient mixed meal tolerance test for patients with Type 1 diabetes?
ea0024oc3.3
Oral Communications 4 (Brief Communications)
Cyclical variation in the incidence of type 1 diabetes in children from northeast England
ea0024oc4.1
Medium term impact of continuous subcutaneous insulin infusion (CSII) on HbA1c levels: A regional meta-analysis of 185 patients
ea0024oc4.2
Maintaining optimum glycaemic control in children with diabetes during Day Case Endoscopy
ea0024oc4.3
Support for insulin injections in schools -- a survey
ea0024oc4.4
Oral Presentations (RCN CYP diabetes session)
(1)
Insulin pump therapy in children with type 1 diabetes and its effect on growth and metabolism: 4 years experience
ea0024op1.1
An audit of education and knowledge surrounding social aspects of type 1 diabetes in adolescents
ea0024op1.2
Intensive insulin therapy in adolescent type 2 diabetes
ea0024op1.3
Differences in metabolic effects of twice daily versus multiple daily insulin injections in children with type 1 diabetes
ea0024op1.4
Lack of 'Hawthorn Effect' in a diabetes pump clinic
ea0024op1.5
Brief Communications (Endocrine Nurse session)
(1)
Investigation of premature adrenarche reveals a high incidence of congenital adrenal hyperplasia (CAH)
ea0024bc1.1
Knowledge, perceptions and actions of obese paediatric patients
ea0024bc1.2
Experience of management of children and adolescents with thyrotoxicosis in the West of Scotland 1987--2009
ea0024bc1.3
Lessons from Klinefelter syndrome (47,XXY): a common DSD but with significant variation in presentation
ea0024bc1.4
Exploration of the perceived information needs of girls with Turner Syndrome and their parents
ea0024bc1.5
Poster Presentations
(1)
Adverse drug reactions and corticosteroids in acute paediatric admissions
ea0024p1
Optimization of treatment in children with 21-hydroxylase deficiency using cortisol profiling
ea0024p2
Pseudohypoaldosteronism Type 1 in Infants: A UK Experience
ea0024p3
Neonatal adrenal suppression from maternal steroid use: A retrospective case note study
ea0024p4
A 30 years review of congenital adrenal hyperplasia in Northern Ireland
ea0024p5
Adrenal responses to a simplified low dose short synacthen test (LDSST) in children with asthma
ea0024p6
Glucocorticoid hypofunction in Myotonic Dystrophy
ea0024p7
Comparison of the low dose synacthen and glucagon stimulation tests in the assessment of adrenal function in children with short stature
ea0024p8
Classical CAH due to a rare compound heterozygote mutation masquerading as pubarche in a 3 years old girl
ea0024p9
Transient hypocortisolemia in post-operative cardiac patients: is it a cause for concern?
ea0024p10
Investigating children of glucocorticoid remediable aldosteronism patients' -- early testing is beneficial
ea0024p11
A family kindred with persistent Mullerian duct syndrome secondary to AMH deficiency
ea0024p12
The European DSD register -- the start of an international DSD network
ea0024p13
Evaluation of terminology used to describe disorders of sex development
ea0024p14
Clitoral and penile sizes in healthy newborn babies in Ibadan, Nigeria
ea0024p15
IGF-2 deficiency in the growth disorder 3-M syndrome
ea0024p16
Feasibility of follow-up in short, small for gestational age (SGA) infants at 2 years -- interim report
ea0024p17
The effect of pubertal timing on later adult obesity
ea0024p18
Outcome of rhGH treatment in patients with achondroplasia and skeletal dysplasias
ea0024p19
Retrospective analysis of patients with paediatric diagnosis of isolated growth hormone deficiency in a single centre from 1970-2000
ea0024p20
Endocrine, hypothalamic and neuro-developmental outcomes following treatment for craniopharyngiomas
ea0024p21
GHT does not improve QOL in all conditions
ea0024p22
The impact of inflammatory bowel disease on pubertal growth is most marked in boys with Crohn's disease
ea0024p23
Short stature with deletion of chromosome 15q and duplication of 16q (q26.3:q23.1)
ea0024p24
Leucine sensitive hyperinsulinaemic hypoglycaemia in patients with 3-hydroxyacyl-coenzyme A dehydrogenase deficiency (HADH)
ea0024p25
Stem cell lines derived from patients with congenital hyperinsulinism
ea0024p26
Feeding problems and their associated predictive factors in congenital hyperinsulinism of infancy (CHI)
ea0024p27
Properties of a pancreatic side-population stem cell lines from a patient with congenital hyperinsulinism
ea0024p28
Cardiac abnormalities in children with congenital hyperinsulinism (CHI)
ea0024p29
Pigmentary hypertrichosis and non autoimmune insulin dependent diabetes mellitus (PHID) syndrome is associated with chronic inflammation and elevated serum amyloid A protein
ea0024p30
An unusual case of diabetes complicated by massive insulin oedema following onset of insulin therapy
ea0024p31
Is point-of-care glucose testing sufficiently accurate to be reliably used for clinical decision-making?
ea0024p32
Audit comparing the body-mass index (BMI) of children, with type 1 diabetes, in Nottingham, with current and historical background populations in the UK
ea0024p33
Undefined diabetes unfolds
ea0024p34
NAFLD in type 1 DM: a report of 2 cases
ea0024p35
MCADD and IDDM-A rare combination
ea0024p36
Type 2 diabetes in childhood: building a platform for interventions to prevent the progression to cardiovascular disease
ea0024p37
Insulin oedema in children with type 1 diabetes mellitus
ea0024p38
Case series: is thiamine responsive megaloblastic anaemia and diabetes associated with cardiac anomalies
ea0024p39
An audit on the process of transition from the paediatric diabetes service to the adult service at the University Hospital of Wales
ea0024p40
It's not just Coeliac disease: gastroenterology referrals from a paediatric diabetes clinic
ea0024p41
Molecular genetic testing for hypophosphatemic rickets
ea0024p42
Vitamin D status in paediatric oncology patients compared to control subjects: grounds for targeted supplementation
ea0024p43
A lifetime of aches, pains and hypocalcaemia
ea0024p44
Metabolic bone disease of prematurity
ea0024p45
Trends in clinical activity of a paediatric bone densitometry service
ea0024p46
Prevalence of congenital hypothyroidism (CHT) in infants presenting with prolonged jaundice
ea0024p47
A rare complication of Hashimoto's thyroiditis
ea0024p48
Timing of the first Guthrie test in preterm infants (32 weeks gestation or less) in Scotland and the efficiency of rescreening
ea0024p49
Why the confusion in Hashimoto's encephalopathy?
ea0024p50
Birth weight, thyroid function, calcitonin levels and growth in children with congenital hypothyroidism
ea0024p51
UK trends in the treatment of young patients with thyrotoxicosis using radioiodine
ea0024p52
A novel disorder of increased energy expenditure with severe failure to gain weight and increased brown fat
ea0024p53
Association of malaria in pregnancy with maternal metabolic biomarkers, cord blood IGF-I and birth size in Nigerian infants: 'The Ibadan Growth and Vascular Health Study'
ea0024p54
A review of the endocrine transition service over the last 10 years
ea0024p55
Hyperandrogensim secondary to topical testosterone exposure
ea0024p56
Retrospective audit of endocrine late effects in survivors of childhood cancer
ea0024p57
Persistent hypernatremia in infants...think diabetes insipidus
ea0024p58
An unusual spectrum of phenotype in autoimmune polyendocrinopathy syndrome type 1: a case series of 5 patients within a single centre
ea0024p59